Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounding and the Courts

Author(s):  Gibbs Jeffrey N, Wasserstein Jeffrey N

Issue:  Jul/Aug 2002 - Compounding for BHRT and Legal and Regulatory Issues
View All Articles in Issue

Page(s):  263-266

Compounding and the Courts Page 1
Compounding and the Courts Page 2
Compounding and the Courts Page 3
Compounding and the Courts Page 4

Download in electronic PDF format for $75

Abstract:  

Related Keywords: FDAMA Section 503A, effect of

Related Categories: BUSINESS, LEGAL

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
Sep/Oct 2014
Pg. 379-380

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Compounding and the Courts
Gibbs Jeffrey N
, Wasserstein Jeffrey N
Jul/Aug 2002
Pg. 263-266

Basics of Compounding for Terrorist Attacks, Part 2
Allen Loyd V Jr
Mar/Apr 2003
Pg. 129-134

View Sample
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon
, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018
Pg. 7-16

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success
Pritchett Jon
, Mixon William, O'Connell Kevin
Jan/Feb 2016
Pg. 29-36

Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph
, Bennet Daron, Allen Loyd V Jr
Mar/Apr 2018
Pg. 95-107

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, LlambĂ­ Francesc
Jan/Feb 2014
Pg. 6-12

Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
May/Jun 2004
Pg. 206-209

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William
, Roth Abby
May/Jun 2017
Pg. 193-203

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns
Allen Loyd V Jr
Jan/Feb 1999
Pg. 25-29

Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Rhoads Rick
Mar/Apr 2018
Pg. 129-134

Compounding OTC Drugs: A Legal Perspective
Gibbs Jeffrey N
, Mazan Kate Duffy
May/Jun 2000
Pg. 180-181

Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Zur Eyal
Mar/Apr 2012
Pg. 117-124

A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies
Hall Essence
, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
May/Jun 2021
Pg. 197-204

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392

Return to Top